Hidradenitis suppurativa (HS) is a painful, chronic skin condition that affects roughly 1% to 2% of people in the U.S.—yet it remains widely misunderstood. Characterized by inflamed, boil-like bumps that can rupture and cause severe discomfort, HS can have a profound impact on daily life. Now, new research suggests that semaglutide—best known as the active ingredient in weight-loss drugs like Wegovy and diabetes meds like Ozempic—may help reduce HS flare-ups, particularly in patients with obesity. Click here to read more.
